Sudha Biddinger, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipogenesis | 9 | 2021 | 212 | 1.700 |
Why?
|
| Receptor, Insulin | 15 | 2022 | 846 | 1.650 |
Why?
|
| Liver | 25 | 2022 | 7470 | 1.480 |
Why?
|
| Insulin | 21 | 2022 | 6575 | 1.390 |
Why?
|
| Insulin Resistance | 16 | 2021 | 3861 | 1.210 |
Why?
|
| Cholesterol | 7 | 2020 | 2895 | 1.070 |
Why?
|
| Hypercholesterolemia | 5 | 2022 | 1149 | 1.040 |
Why?
|
| Gluconeogenesis | 6 | 2018 | 183 | 0.950 |
Why?
|
| Methylamines | 2 | 2019 | 117 | 0.820 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 4 | 2022 | 137 | 0.790 |
Why?
|
| Leptin | 7 | 2018 | 1593 | 0.720 |
Why?
|
| Serine Endopeptidases | 2 | 2016 | 1073 | 0.720 |
Why?
|
| Oxygenases | 2 | 2019 | 60 | 0.690 |
Why?
|
| Gene Expression Regulation | 9 | 2017 | 12071 | 0.670 |
Why?
|
| Hyperlipidemias | 2 | 2022 | 786 | 0.670 |
Why?
|
| eIF-2 Kinase | 1 | 2019 | 150 | 0.670 |
Why?
|
| Dyslipidemias | 3 | 2019 | 848 | 0.660 |
Why?
|
| Lipodystrophy | 2 | 2016 | 147 | 0.630 |
Why?
|
| Hepatocytes | 6 | 2017 | 1209 | 0.620 |
Why?
|
| Fructose | 2 | 2017 | 288 | 0.620 |
Why?
|
| Mice, Obese | 6 | 2019 | 424 | 0.620 |
Why?
|
| Triglycerides | 9 | 2021 | 2450 | 0.570 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 2 | 2014 | 52 | 0.570 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2015 | 60 | 0.560 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2022 | 3336 | 0.550 |
Why?
|
| Obesity | 8 | 2020 | 12705 | 0.530 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 2006 | 86 | 0.530 |
Why?
|
| Proprotein Convertases | 1 | 2016 | 95 | 0.520 |
Why?
|
| Forkhead Transcription Factors | 4 | 2015 | 1613 | 0.500 |
Why?
|
| Mice, Knockout | 19 | 2019 | 14554 | 0.500 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2020 | 11695 | 0.500 |
Why?
|
| Lovastatin | 1 | 2014 | 120 | 0.460 |
Why?
|
| Hepatitis | 1 | 2015 | 227 | 0.460 |
Why?
|
| Nephrotic Syndrome | 1 | 2016 | 389 | 0.420 |
Why?
|
| Glucose | 5 | 2018 | 4391 | 0.410 |
Why?
|
| Apolipoproteins B | 1 | 2013 | 373 | 0.400 |
Why?
|
| Mice | 34 | 2023 | 81045 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 13 | 2023 | 21821 | 0.350 |
Why?
|
| Diet, Fat-Restricted | 2 | 2017 | 317 | 0.330 |
Why?
|
| Phosphoproteins | 1 | 2017 | 2440 | 0.330 |
Why?
|
| Atherosclerosis | 3 | 2019 | 3428 | 0.320 |
Why?
|
| Animals | 39 | 2023 | 168561 | 0.320 |
Why?
|
| Hep G2 Cells | 2 | 2019 | 392 | 0.300 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 2915 | 0.290 |
Why?
|
| Cholelithiasis | 1 | 2008 | 411 | 0.290 |
Why?
|
| Gene Knockdown Techniques | 4 | 2015 | 1655 | 0.280 |
Why?
|
| Bile Acids and Salts | 3 | 2022 | 353 | 0.270 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2005 | 123 | 0.260 |
Why?
|
| Blood Glucose | 11 | 2019 | 6249 | 0.250 |
Why?
|
| RNA, Messenger | 5 | 2015 | 13029 | 0.240 |
Why?
|
| Cholesterol, LDL | 3 | 2022 | 2354 | 0.240 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2018 | 2014 | 0.240 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 286 | 0.240 |
Why?
|
| Dietary Fats | 4 | 2013 | 2017 | 0.230 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2005 | 423 | 0.230 |
Why?
|
| Receptors, Leptin | 3 | 2018 | 356 | 0.220 |
Why?
|
| Glycemic Index | 1 | 2005 | 395 | 0.220 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 1 | 2022 | 9 | 0.210 |
Why?
|
| Apolipoprotein C-III | 2 | 2016 | 202 | 0.210 |
Why?
|
| Gene Expression | 4 | 2018 | 7790 | 0.210 |
Why?
|
| Mice, Transgenic | 5 | 2018 | 9735 | 0.200 |
Why?
|
| Sitosterols | 1 | 2020 | 9 | 0.190 |
Why?
|
| Phytosterols | 1 | 2020 | 65 | 0.190 |
Why?
|
| Signal Transduction | 11 | 2018 | 23387 | 0.180 |
Why?
|
| Simvastatin | 1 | 2022 | 360 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3239 | 0.170 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2017 | 38 | 0.160 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2017 | 73 | 0.160 |
Why?
|
| Transcription Factors | 5 | 2017 | 12164 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2016 | 5180 | 0.150 |
Why?
|
| MicroRNAs | 3 | 2019 | 3731 | 0.150 |
Why?
|
| Lipids | 3 | 2018 | 3302 | 0.140 |
Why?
|
| Fatty Acids | 2 | 2018 | 1806 | 0.140 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 2030 | 0.140 |
Why?
|
| Crosses, Genetic | 2 | 2015 | 791 | 0.140 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2018 | 311 | 0.140 |
Why?
|
| Lipoproteins | 3 | 2008 | 876 | 0.140 |
Why?
|
| Pyruvate Kinase | 1 | 2018 | 189 | 0.140 |
Why?
|
| Oligonucleotides | 1 | 2019 | 572 | 0.140 |
Why?
|
| Transcriptional Activation | 2 | 2014 | 1782 | 0.140 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 15108 | 0.130 |
Why?
|
| Jejunum | 1 | 2018 | 480 | 0.130 |
Why?
|
| Mice, 129 Strain | 2 | 2014 | 386 | 0.130 |
Why?
|
| Biosynthetic Pathways | 2 | 2014 | 137 | 0.130 |
Why?
|
| HEK293 Cells | 3 | 2019 | 4200 | 0.130 |
Why?
|
| Gallstones | 1 | 2008 | 286 | 0.130 |
Why?
|
| Fatty Liver | 2 | 2012 | 728 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 2018 | 390 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2022 | 657 | 0.130 |
Why?
|
| DNA-Binding Proteins | 3 | 2011 | 9639 | 0.130 |
Why?
|
| Anthropometry | 1 | 2019 | 1350 | 0.120 |
Why?
|
| Energy Intake | 2 | 2017 | 2147 | 0.120 |
Why?
|
| Oxidation-Reduction | 2 | 2018 | 2187 | 0.120 |
Why?
|
| Half-Life | 1 | 2015 | 658 | 0.120 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2018 | 584 | 0.120 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2017 | 2211 | 0.120 |
Why?
|
| Mass Spectrometry | 2 | 2019 | 2203 | 0.120 |
Why?
|
| Cholesterol, Dietary | 2 | 2008 | 231 | 0.120 |
Why?
|
| Male | 20 | 2019 | 349538 | 0.120 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2023 | 1181 | 0.110 |
Why?
|
| Young Adult | 6 | 2020 | 56350 | 0.110 |
Why?
|
| Rats | 5 | 2019 | 24265 | 0.110 |
Why?
|
| Humans | 27 | 2023 | 742088 | 0.110 |
Why?
|
| Hyperglycemia | 2 | 2015 | 1368 | 0.110 |
Why?
|
| Random Allocation | 1 | 2017 | 2425 | 0.110 |
Why?
|
| Receptors, LDL | 1 | 2015 | 475 | 0.110 |
Why?
|
| Azetidines | 1 | 2014 | 142 | 0.110 |
Why?
|
| Fasting | 3 | 2014 | 1589 | 0.110 |
Why?
|
| Lipoproteins, VLDL | 1 | 2013 | 201 | 0.110 |
Why?
|
| Podocytes | 1 | 2016 | 394 | 0.110 |
Why?
|
| Phospholipids | 1 | 2015 | 781 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2015 | 1121 | 0.100 |
Why?
|
| Ketones | 1 | 2012 | 189 | 0.100 |
Why?
|
| Indoles | 1 | 2019 | 1834 | 0.100 |
Why?
|
| Protein Kinase C-delta | 1 | 2011 | 123 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2008 | 559 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 1213 | 0.090 |
Why?
|
| Models, Animal | 3 | 2014 | 2170 | 0.090 |
Why?
|
| Metagenome | 1 | 2013 | 417 | 0.090 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2010 | 52 | 0.090 |
Why?
|
| Hypothalamic Hormones | 1 | 2010 | 147 | 0.090 |
Why?
|
| Pituitary Hormones | 1 | 2010 | 183 | 0.090 |
Why?
|
| Sirtuin 3 | 1 | 2010 | 68 | 0.090 |
Why?
|
| Choline | 2 | 2023 | 487 | 0.090 |
Why?
|
| Liver Diseases | 2 | 2008 | 1252 | 0.090 |
Why?
|
| Gastric Bypass | 1 | 2018 | 812 | 0.090 |
Why?
|
| Melanins | 1 | 2010 | 288 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3862 | 0.080 |
Why?
|
| Steroid Hydroxylases | 1 | 2008 | 96 | 0.080 |
Why?
|
| Cholesterol, HDL | 1 | 2015 | 1813 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2018 | 7873 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4751 | 0.080 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 814 | 0.080 |
Why?
|
| Adolescent | 4 | 2020 | 85649 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2018 | 4024 | 0.070 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2008 | 91 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2010 | 867 | 0.070 |
Why?
|
| Rats, Zucker | 2 | 2019 | 128 | 0.070 |
Why?
|
| Dietary Carbohydrates | 1 | 2012 | 904 | 0.070 |
Why?
|
| Body Weight | 3 | 2010 | 4664 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 6608 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2017 | 2585 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2014 | 2186 | 0.070 |
Why?
|
| RNA Interference | 2 | 2012 | 2890 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 2018 | 5019 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 3444 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2502 | 0.070 |
Why?
|
| Female | 13 | 2019 | 379592 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2022 | 314 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3920 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2020 | 21719 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2010 | 1063 | 0.060 |
Why?
|
| Hypertriglyceridemia | 1 | 2008 | 293 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 8300 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2010 | 1359 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2012 | 2968 | 0.060 |
Why?
|
| Cell Line | 2 | 2015 | 15994 | 0.060 |
Why?
|
| Bacteria | 1 | 2013 | 2102 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2020 | 12695 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 2866 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 1827 | 0.050 |
Why?
|
| Sex Factors | 1 | 2016 | 10392 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2022 | 2751 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4249 | 0.050 |
Why?
|
| Base Sequence | 2 | 2019 | 12797 | 0.050 |
Why?
|
| DNA Primers | 1 | 2006 | 2892 | 0.050 |
Why?
|
| Child | 3 | 2019 | 77478 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2008 | 1780 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9410 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2007 | 6171 | 0.050 |
Why?
|
| Adult | 6 | 2020 | 213712 | 0.040 |
Why?
|
| Homeostasis | 1 | 2011 | 3335 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2012 | 19223 | 0.040 |
Why?
|
| Diet, Atherogenic | 1 | 2019 | 95 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 24913 | 0.040 |
Why?
|
| Neoplasms | 2 | 2018 | 21596 | 0.040 |
Why?
|
| Up-Regulation | 3 | 2014 | 4211 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2019 | 40450 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 2867 | 0.040 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 5724 | 0.040 |
Why?
|
| Mitochondria | 1 | 2010 | 3520 | 0.040 |
Why?
|
| Glucose Tolerance Test | 2 | 2010 | 1150 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 808 | 0.030 |
Why?
|
| Risk Factors | 2 | 2019 | 72145 | 0.030 |
Why?
|
| Diet | 1 | 2013 | 7923 | 0.030 |
Why?
|
| Glycosylation | 1 | 2018 | 1123 | 0.030 |
Why?
|
| Bilophila | 1 | 2013 | 6 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2014 | 67 | 0.030 |
Why?
|
| Food Microbiology | 1 | 2013 | 78 | 0.030 |
Why?
|
| Fermentation | 1 | 2013 | 143 | 0.030 |
Why?
|
| Bacteroides | 1 | 2013 | 161 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 40955 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18006 | 0.030 |
Why?
|
| Swine | 1 | 2023 | 5934 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2019 | 2378 | 0.030 |
Why?
|
| Diet, Vegetarian | 1 | 2013 | 173 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2014 | 8436 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2014 | 476 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 475 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2010 | 117 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2019 | 2500 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2011 | 682 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2017 | 3001 | 0.020 |
Why?
|
| Carnitine | 1 | 2010 | 239 | 0.020 |
Why?
|
| Counseling | 1 | 2017 | 1521 | 0.020 |
Why?
|
| Body Temperature Regulation | 1 | 2010 | 252 | 0.020 |
Why?
|
| Time Factors | 3 | 2017 | 40054 | 0.020 |
Why?
|
| Lentivirus | 1 | 2010 | 501 | 0.020 |
Why?
|
| Feces | 1 | 2013 | 1394 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2008 | 266 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2013 | 1119 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2010 | 302 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 561 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1085 | 0.020 |
Why?
|
| Thinness | 1 | 2010 | 479 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 2011 | 577 | 0.020 |
Why?
|
| Species Specificity | 1 | 2011 | 2479 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 822 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2007 | 176 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2010 | 774 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 402 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2010 | 1875 | 0.020 |
Why?
|
| Weight Loss | 1 | 2017 | 2604 | 0.020 |
Why?
|
| Neuroglia | 1 | 2010 | 925 | 0.020 |
Why?
|
| Adipose Tissue, Brown | 1 | 2010 | 754 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9305 | 0.010 |
Why?
|
| Eating | 1 | 2010 | 1535 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2010 | 2024 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 2010 | 859 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5892 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2007 | 1727 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 1887 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6365 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 9581 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 1899 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2010 | 3420 | 0.010 |
Why?
|
| Adiposity | 1 | 2010 | 1806 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 1670 | 0.010 |
Why?
|
| Age Factors | 1 | 2017 | 18355 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5867 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 2410 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2010 | 2956 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2010 | 3278 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16665 | 0.010 |
Why?
|
| Middle Aged | 3 | 2018 | 213127 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2008 | 2896 | 0.010 |
Why?
|
| Aging | 1 | 2011 | 8626 | 0.010 |
Why?
|
| Neurons | 1 | 2010 | 9325 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 62966 | 0.010 |
Why?
|
| Mutation | 1 | 2011 | 29717 | 0.000 |
Why?
|